Caption Management, LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $972,000 - $2.05 Million	-30,000 Reduced 50.0%	30,000 $2.04 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $669,000 - $1.12 Million	30,000 Added 100.0%	60,000 $1.92 Million
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $770,400 - $1.07 Million	30,000 New	30,000 $1.04 Million
Q4 2021 Feb 11, 2022	SELL	$24.9 - $40.26 $4.98 Million - $8.05 Million	-200,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $2.74 Million - $4.01 Million	107,400 Added 115.98%	200,000 $5.1 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $2.19 Million - $2.94 Million	67,600 Added 270.4%	92,600 $3.25 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $389,400 - $508,500	-10,000 Reduced 28.57%	25,000 $1.02 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $1.43 Million - $2.42 Million	-37,900 Reduced 51.99%	35,000 $1.52 Million
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $258,524 - $365,001	4,900 Added 7.21%	72,900 $4.02 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $3.31 Million - $5.56 Million	68,000 New	68,000 $4.29 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $3.13 Million - $6.54 Million	-75,000 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$45.7 - $81.86 $2.97 Million - $5.32 Million	-65,000 Reduced 46.43%	75,000 $5.96 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $5.44 Million - $6.95 Million	120,000 Added 600.0%	140,000 $6.79 Million
Q1 2019 May 14, 2019	BUY	$39.99 - $53.48 $199,950 - $267,400	5,000 Added 33.33%	20,000 $1.06 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $580,500 - $752,250	15,000 New	15,000 $678,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account